Hyebin Lee

8PUBLICATIONS
36CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epigenetics (incl. genome methylation and epigenomics)Molecular targetsPredictive and prognostic markersNutrigenomics and personalised nutrition
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 24, 2026
Prognostic impact of radiotherapy dose to the axilla in cN + /ypN0 breast cancer after primary systemic therapy and sentinel lymph node biopsy: toward true de-escalation of axillary management.

|Apr 06, 2026
Tumor-Associated Macrophage Infiltration and PD-L1 Expression in Gastric Cancer According to a Modified TCGA-Based Classification.

Boram Song, Dong-Hoe Koo, Eo Jin Kim

|Jul 22, 2025
MSN/STAT3 drives cancer stemness and chemoresistance via IL-6/LPAR1 ligand receptor complex in triple-negative breast cancer.

Cheng Hyun Lee, Soo Young Park, Jae Seok Lee

|Feb 25, 2023
Evaluation of Pretreatment Albumin-Bilirubin Grade as a Better Prognostic Factor Compared to Child-Pugh Classification in Patients with Hepatocellular Carcinoma Receiving Transarterial Chemoembolization Combined with Radiotherapy.

Jason Joon Bock Lee, Jun Su Park, Hyun Pyo Hong

|Nov 11, 2022
Dual Oxidase 2 (DUOX2) as a Proteomic Biomarker for Predicting Treatment Response to Chemoradiation Therapy for Locally Advanced Rectal Cancer: Using High-Throughput Proteomic Analysis and Machine Learning Algorithm.

Hyebin Lee, Han Suk Ryu, Hee Chul Park

|Sep 02, 2022
Quantitative proteomics identifies TUBB6 as a biomarker of muscle-invasion and poor prognosis in bladder cancer.

Bohyun Kim, Minsun Jung, Kyung Chul Moon

Pageof 2

Frequent Collaborators

4 joint publications

Han Suk Ryu

2 joint publications

Minsun Jung

1 joint publications

Kyung-Min Lee

1 joint publications

Eun Hye Hwang